This makes them a strong option for individuals with: Obesity or severe overweight Insulin resistance or prediabetes Difficulty controlling appetite Easy to Use and Monitor GLP-1s are available in convenient weekly injections and have clearly defined protocols, making them easier for patients to follow compared to the variety of peptide regimens
(129) used Lpc-BoSA/CSO (functionalized lipid NPs) to increase the BBB permeability and facilitate the delivery of peptide drugs like exenatide
( h-k ) Quantification of tumour number ( h ) and size ( i ), with representative H&E and -catenin images ( j-k ), in WT, BDH1 iKO, and OXCT1 iKO mice on CD or KD
PubMed Sikiric P, Seiwerth S, Rucman R, et al
Thus, for example, as noted by the authors, in one study with liraglutide, obese subjects in the quartile of greatest weight loss had a mean weight loss of 18 kg with 3.0 mg of liraglutide compared with only 9 kg on placebo